Key result
Selegiline lowers diet-enhanced cardiac contractility ~21% in obese rats while attenuating proapoptotic signaling.
Why the study?
Moderate obesity reduces the risk of developing cardiovascular disease, and the MAO-B inhibitor selegiline reduces visceral adiposity. However, the cardiac effects of selegiline in moderate obesity induced by a high-fat diet needed investigation.
Does MAO-B inhibition with selegiline affect cardiac contractility, Ca2+ homeostasis, inflammation, and apoptosis in a rat model of high-fat diet-induced moderate obesity?
Does MAO-B inhibition with selegiline affect cardiac contractility, Ca2+ homeostasis, inflammation, and apoptosis in a rat model of high-fat diet-induced moderate obesity?
In a rat model of moderate obesity, high-fat diet improved load-independent cardiac contractility via altered calcium handling and low-grade inflammation, but MAO-B inhibition with selegiline abolished these functional benefits despite reducing apoptotic sensitization.
Answers are grounded in this paper and cite their sources.
May blunt high-fat diet benefits on rat cardiac contractility despite reducing apoptosis; leaves open MAO-B inhibition effects in human cardiometabolic disease.
Background Obesity is a major risk factor for the development of cardiovascular disease. However, recent research shows that moderate obesity reduces the risk of developing cardiovascular disease. We evidenced before that MAO-B inhibitor selegiline reduced visceral adiposity. Aim Therefore, our aim was to investigate cardiac effects of selegiline in moderate obesity in rats treated with a high-fat diet (HFD). Key Findings We demonstrated that HFD improved cardiac contractility parameters, which were reversed by selegiline. Enhanced contractility might be attributed to an increased sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase (SERCA2a) expression and phospholamban pentamerization. Selegiline reduced SERCA2a expression in HFD. HFD increased Tumor necrosis factor and Nuclear factor-kappa B expression which were not affected by selegiline. HFD induced proapoptotic processes, which were restored by selegiline. Conclusion In conclusion, moderate obesity improves cardiac function through Ca 2+ homeostasis and inflammatory processes and MAO-B inhibition reverses these effects.
No takes yet. Share an insight, caveat, or question.
Hambalkó et al. (2025) studied Diet-induced moderate obesity (preclinical model) (n=40). Selegiline vs. High-fat diet (HFD) alone and Control diet (CON) with or without selegiline was evaluated on Load-independent cardiac contractility parameters: End systolic pressure-volume relationship (ESPVR, mmHg/μl) (p=<0.05). Selegiline reversed the high-fat diet-induced improvements in cardiac contractility in moderately obese rats while attenuating proapoptotic sensitization.
Synapse has enriched 10 related papers. Consider them for comparative context: